Location History:
- St John's, CA (2008)
- St. John's, CA (2003 - 2010)
- Dix Hills, NY (US) (2017)
Company Filing History:
3 out of 153 
1 out of 21 
Years Active: 2003-2017
Title: Innovations by Tarun Wasil in Chronic Lymphocytic Leukemia
Introduction
Tarun Wasil is an accomplished inventor based in Dix Hills, NY (US). He has made significant contributions to the field of medical research, particularly in the area of chronic lymphocytic leukemia (CLL). With a total of four patents to his name, Wasil's work focuses on improving prognostic methods for patients diagnosed with B-CLL.
Latest Patents
One of Wasil's latest patents is titled "CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia." This invention discloses a method for determining the prognosis and probable clinical course of a subject diagnosed with B-CLL. Specifically, the invention involves comparing CD38 expression in a biological sample from the subject containing B-CLL cells to a baseline level of CD38 expression. An elevated level of CD38 expression in relation to the baseline may indicate a poor prognosis or an aggressive course of the disease. Additionally, the patent outlines a method for determining whether the immunoglobulin variable (Ig V) genes of the B-CLL cells are mutated. This is achieved by comparing CD38 expression in a biological sample, where a lower level of CD38 expression indicates an Ig V gene mutation.
Career Highlights
Throughout his career, Tarun Wasil has worked with notable institutions such as the Feinstein Institute for Medical Research and North Shore-LIJ Research Institute. His research has focused on enhancing the understanding of CLL and developing innovative methods for patient prognosis.
Collaborations
Wasil has collaborated with esteemed colleagues in the field, including Nicholas Chiorazzi and Rajendra N. Damle. Their combined expertise has contributed to advancements in the understanding and treatment of chronic lymphocytic leukemia.
Conclusion
Tarun Wasil's innovative work in the field of chronic lymphocytic leukemia has the potential to significantly impact patient care and prognosis. His contributions through patents and collaborations highlight the importance of research in advancing medical science.